Literature DB >> 26340164

Ethnicity influences pain after ultrasound-guided percutaneous liver biopsy.

Sanjiv Mahadeva1, Anis S Mahfudz, Anushya Vijayananthan.   

Abstract

BACKGROUND: The influence of ethnicity on pain complicating ultrasound-guided percutaneous liver biopsy (US-guided PLB) and its clinical impact has not been reported to date.
METHODS: Consecutive adults from a multiethnic background, undergoing an US-guided PLB, were independently assessed for pain up to 6 h after the procedure. Clinical and demographic parameters were analysed to determine independent predictors of significant pain after PLB. Willingness to undergo a repeat procedure was assessed 1 week after PLB.
RESULTS: Data from 203 patients (median age 50 years; 43.9% female; ethnicity: Malay 41.5%, Chinese 40%, Indian 18%; median BMI 27.7 kg/m; median waist circumference 92.0 cm) were analysed. Pain after US-guided PLB was experienced in 133 (61.1%) patients, with severity grades as follows: none, n=81 (39.9%); mild, n=56 (27.6%); moderate, n=51 (25.1%); and severe, n=15 (7.4%). Analgesia requirements correlated well with severity of pain. Independent predictors of significant pain after PLB (moderate and severe categories) in patients included age less than 50 years [odds ratio (OR) 3.0], female sex (OR 3.7), Indian ethnicity (OR 2.9) and Malay ethnicity (OR 2.7), but not number of needle passes, BMI and educational levels. Patients who experienced moderate/severe pain were less willing to undergo a repeat PLB compared with those who experienced mild/no pain (60.9 vs. 82.8%, P=0.001).
CONCLUSION: Ethnicity has an important role in the development of pain after US-guided PLB. This has a significant impact on willingness to repeat the procedure.

Entities:  

Mesh:

Year:  2015        PMID: 26340164     DOI: 10.1097/MEG.0000000000000465

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

1.  Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B.

Authors:  Donna M Evon; Hsing-Hua S Lin; Robert J Fontana; Mandana Khalili; Colina Yim; Abdus S Wahed; Jay H Hoofnagle
Journal:  GastroHep       Date:  2021-05-05

2.  Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.

Authors:  Lee-Lee Lai; Wah-Kheong Chan; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Khean-Lee Goh; Sanjiv Mahadeva
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

3.  Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis.

Authors:  Sivesh K Kamarajah; Stanley Khoo; Wah-Kheong Chan; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva
Journal:  JGH Open       Date:  2019-04-04

4.  Experiences With Machismo and Pain: Latino Veterans.

Authors:  Roberto Cancio
Journal:  Am J Mens Health       Date:  2020 Nov-Dec

5.  Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Helena B Thomaides-Brears; Naim Alkhouri; Daniela Allende; Mukesh Harisinghani; Mazen Noureddin; Nancy S Reau; Marika French; Carlos Pantoja; Sofia Mouchti; Donna R H Cryer
Journal:  Dig Dis Sci       Date:  2021-06-15       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.